Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Far Red Light to Improve Functioning in PAD

NCT: NCT06165016 · ACTIVE_NOT_RECRUITING

NCT IDNCT06165016
StatusACTIVE_NOT_RECRUITING
Start Date2024-02-14
Completion2026-12-31
SponsorNorthwestern University (OTHER)
First posted
Last updated

Brief Summary

The LIGHT PAD Trial is a Phase II multi-centered randomized clinical trial to collect preliminary data to test whether daily far red light treatment of the lower extremities in people with PAD improves six-minute walk distance, lower extremity perfusion, and ischemia-related damage in gastrocnemius muscle at four-month follow-up, compared to a sham control. Participants will complete 10 minutes of twice daily home treatment with either far red light or a sham light for four months.

Frequently Asked Questions

What is Far Red Light to Improve Functioning in PAD?

Far Red Light to Improve Functioning in PAD is a clinical trial registered under NCT06165016. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06165016?

The current status of NCT06165016 (Far Red Light to Improve Functioning in PAD) is: ACTIVE_NOT_RECRUITING.

When did Far Red Light to Improve Functioning in PAD start?

Far Red Light to Improve Functioning in PAD started on 2024-02-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.